The European Working Group of People with Dementia (EWGPWD) began its third two-year term of office at a meeting held on 30 October 2016 in Copenhagen.

Following its AGM, AE is pleased to announce it has a new Board, new Chairperson and two new member associations.

The 26^th Alzheimer Europe Conference was held on 31 October - 2 November in Copenhagen together with Alzheimerforeningen, Denmark’s national Alzheimer association.

On 16 November, the ROADMAP initiative - Real world Outcomes across the Alzheimer’s Disease (AD) spectrum for better care: Multi-modal data Access Platform - launched.

Eli Lilly’s experimental Alzheimer’s drug solanezumab, which had previously shown promise, has failed in its Phase III clinical trial, it was announced on 23 November.

​​On 24 November 2016, Switzerland anounced that the ​​Confederation and cantons have decided to prolong the National Dementia Strategy until 2019.